During the Trading Day
| 5.84 | -0.20 / -3.31% |
Data as of 4:00pm ET | Day’s Change | |
| 5.84 | 0.00 / 0.00% |
| Volume: 4.6K |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $341.3M |
Company Description
Depomed, Inc. manufactures and distributes pharmaceutical products. It is a specialty pharmaceutical company focused on the development and commercialization of differentiated products that address large and growing markets and are based on proprietary oral drug delivery technologies. Its products are Gralise and Glumetz. The company was founded on August 7, 1995 by John W. Shell and is headquartered in Menlo Park, CA.
Employees

Shareholders
| Other institutional | 50.11% |
| Mutual fund holders | 14.54% |
| Individual stakeholders | 11.88% |
Top Executives
| James A. Schoeneck | President, Chief Executive Officer & Director |
| August J. Moretti | CFO, Senior VP & Head-Investor Relations |
| Michael Sweeney, MD | Chief Medical Officer, VP-Research & Development |
| Matthew M. Gosling | Senior Vice President & General Counsel |
| Jack Anders | Senior Director-Finance |